Home
>
National Drug Code (NDC)
>
Tabradol
Tabradol - 43093-101-01 - (Cyclobenzaprine Hydrochloride)
Drug Information of Tabradol
| Product NDC: | 43093-101 |
| Proprietary Name: | Tabradol |
| Non Proprietary Name: | Cyclobenzaprine Hydrochloride |
| Active Ingredient(s): | & nbsp; Cyclobenzaprine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tabradol
| Product NDC: | 43093-101 |
| Labeler Name: | Fusion Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20090917 |
Package Information of Tabradol
| Package NDC: | 43093-101-01 |
| Package Description: | 1 KIT in 1 KIT (43093-101-01) * .25 g in 1 BOTTLE, GLASS * 125 mL in 1 BOTTLE, PLASTIC * 125 mL in 1 BOTTLE, PLASTIC |
NDC Information of Tabradol
| NDC Code | 43093-101-01 |
| Proprietary Name | Tabradol |
| Package Description | 1 KIT in 1 KIT (43093-101-01) * .25 g in 1 BOTTLE, GLASS * 125 mL in 1 BOTTLE, PLASTIC * 125 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 43093-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyclobenzaprine Hydrochloride |
| Dosage Form Name | KIT |
| Route Name | ORAL |
| Start Marketing Date | 20090917 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Fusion Pharmaceuticals LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
